🇺🇸 Peginterferon alpha in United States

50 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Anaemia — 8 reports (16%)
  2. Drug Interaction — 8 reports (16%)
  3. Bone Marrow Failure — 7 reports (14%)
  4. Rash — 5 reports (10%)
  5. Asthenia — 4 reports (8%)
  6. Nausea — 4 reports (8%)
  7. Pruritus — 4 reports (8%)
  8. Thrombocytopenia — 4 reports (8%)
  9. Fatigue — 3 reports (6%)
  10. Malaise — 3 reports (6%)

Source database →

Frequently asked questions

Is Peginterferon alpha approved in United States?

Peginterferon alpha does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Peginterferon alpha in United States?

Merck Sharp & Dohme LLC is the originator. The local marketing authorisation holder may differ — check the official source linked above.